Pages that link to "Q33733751"

The following pages link to Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer (Q33733751):

Displaying 21 items.

• Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer (Q26764932) (← links)
• Second-line treatment of metastatic gastric cancer: Current options and future directions (Q26778027) (← links)
• From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer (Q28082921) (← links)
• Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway (Q35781460) (← links)
• Global transcriptome and sequenome analysis of formalin-fixed salivary epithelial-myoepithelial carcinoma specimens (Q36838327) (← links)
• FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma (Q37067161) (← links)
• Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor (Q37225517) (← links)
• Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer (Q37567109) (← links)
• A novel gene expression-based prognostic scoring system to predict survival in gastric cancer (Q37688244) (← links)
• Therapeutic targeting of fibroblast growth factor receptors in gastric cancer. (Q38497265) (← links)
• FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival (Q40733626) (← links)
• Established gastric cancer cell lines transplantable into C57BL/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth. (Q52430780) (← links)
• Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma. (Q53128013) (← links)
• Fibroblast growth factor receptors as treatment targets in clinical oncology (Q58115640) (← links)
• FGFR1 is an independent prognostic factor and can be regulated by miR-497 in gastric cancer progression (Q60050923) (← links)
• Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis (Q60922986) (← links)
• Overexpression of FGFR1 Promotes Peritoneal Dissemination Via Epithelial-to-Mesenchymal Transition in Gastric Cancer (Q89433590) (← links)
• Long non-coding RNA ANRIL promotes tumorgenesis through regulation of FGFR1 expression by sponging miR-125a-3p in head and neck squamous cell carcinoma (Q90573190) (← links)
• LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer (Q90585097) (← links)
• Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer (Q92282798) (← links)
• The changing face of gastric cancer: epidemiologic trends and advances in novel therapies (Q100428137) (← links)